Alison Jones

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study

Bella Kaufman, John R. Mackey, Michael Clemens et al. · Journal of Clinical Oncology · 2009 · 850 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching Hospitals

Alistair Ring, Ian E. Smith, Alison Jones et al. · Journal of Clinical Oncology · 2005 · 278 citations · Full text

Medicine, Obstetrics, Oncology +17

In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.

Mitch Dowsett, Alison Jones, Stephen Johnston et al. · PubMed · 1995 · 239 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The Parallel Rural Community Curriculum: an integrated clinical curriculum based in rural general practice

Paul Worley, Chris Silagy, David Prideaux et al. · Medical Education · 2000 · 222 citations

Medicine, Curriculum, Medical Education +17